CVS HEALTH Corp Long-Term Concentrated

CIK: 0000064803 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 9, 2024

Total Value ($000): $193,740 (100.0% shares, 0.0% debt)

Holdings (6)

SPY SPDR S P 500 ETF TRUST 70.6%

Value ($000) $136,837 Shares 287,891 Est. Cost $432.89 Unrealized —

VYM VANGUARD WHITEHALL FDS 14.5%

Value ($000) $28,134 Shares 252,032 Est. Cost $111.29 Unrealized —

HDV ISHARES CORE HIGH DIVIDEND ETF 14.4%

Value ($000) $27,854 Shares 273,110 Est. Cost $100.99 Unrealized —

— LUMIRADX LTD 0.2%

Value ($000) $337 Shares 5,352,106 Est. Cost $8.91 Unrealized —

HCAT HEALTH CATALYST INC 0.2%

Value ($000) $299 Shares 32,273 Est. Cost $45.57 Unrealized -82.1%

PRU PRUDENTIAL FINANCIAL INC 0.1%

Value ($000) $278 Shares 2,683 Est. Cost $88.87 Unrealized -2.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
SPY	SPDR S P 500 ETF TRUST	287,891	$136,837	70.6%	$432.89	—	COM	78462F103
VYM	VANGUARD WHITEHALL FDS	252,032	$28,134	14.5%	$111.29	—	COM	921946406
HDV	ISHARES CORE HIGH DIVIDEND ETF	273,110	$27,854	14.4%	$100.99	—	COM	46429B663
—	LUMIRADX LTD	5,352,106	$337	0.2%	$8.91	—	COM	G5709L117
HCAT	HEALTH CATALYST INC	32,273	$299	0.2%	$45.57	-82.1%	COM	42225T107
PRU	PRUDENTIAL FINANCIAL INC	2,683	$278	0.1%	$88.87	-2.5%	COM	744320102